These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antiepileptic drug resistance and tolerance in epilepsy. Widdess-Walsh P; Devinsky O Rev Neurol Dis; 2007; 4(4):194-202. PubMed ID: 18195671 [TBL] [Abstract][Full Text] [Related]
5. Lacosamide use in refractory idiopathic primary generalized epilepsy. Zangaladze A; Skidmore C Epilepsy Behav; 2012 Jan; 23(1):79-80. PubMed ID: 22197124 [TBL] [Abstract][Full Text] [Related]
6. Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy. Summers MA; Moore JL; McAuley JW Ann Pharmacother; 2004 Oct; 38(10):1631-4. PubMed ID: 15328394 [TBL] [Abstract][Full Text] [Related]
8. Addressing overtreatment in patients with refractory epilepsy at a tertiary referral centre in Brazil. Alexandre V; Monteiro EA; Freitas-Lima P; Pinto KD; Velasco TR; Terra VC; Pinheiro-Martins AP; Souza RM; Perucca E; Sakamoto AC Epileptic Disord; 2011 Mar; 13(1):56-60. PubMed ID: 21393097 [TBL] [Abstract][Full Text] [Related]
9. Refractory epilepsy: clinical overview. French JA Epilepsia; 2007; 48 Suppl 1():3-7. PubMed ID: 17316406 [TBL] [Abstract][Full Text] [Related]
10. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Canevini MP; De Sarro G; Galimberti CA; Gatti G; Licchetta L; Malerba A; Muscas G; La Neve A; Striano P; Perucca E; Epilepsia; 2010 May; 51(5):797-804. PubMed ID: 20545754 [TBL] [Abstract][Full Text] [Related]
11. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience. Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229 [TBL] [Abstract][Full Text] [Related]